Real-world safety and efficacy of nivolumab for &#8805; 2nd line treatment of metastatic renal cell carcinoma: A retrospective cohort study in Croatia, Hungary, and Malta.

Vrdoljak, Eduard; Magri, Claude; Gamulin, Marija; Boskovic, Lidija; Omrcen, Tomislav; Bajic, Zarko; Dienes, Tamas; Geczi, Lajos

Real-world safety and efficacy of nivolumab for ≥ 2nd line treatment of metastatic renal cell carcinoma: A retrospective cohort study in Croatia, Hungary, and Malta.

Vrdoljak, Eduard; Magri, Claude; Gamulin, Marija; Boskovic, Lidija; Omrcen, Tomislav; Bajic, Zarko; Dienes, Tamas; Geczi, Lajos.

Afiliación

Vrdoljak E; Department of Oncology, University Hospital Split, School of Medicine, University of Split, Split, Croatia.
Magri C; Mater Dei Hospital, Triq Dun Karm, L-Imsida, Malta.
Gamulin M; Department of Oncology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
Boskovic L; Department of Oncology, University Hospital Split, School of Medicine, University of Split, Split, Croatia.
Omrcen T; Department of Oncology, University Hospital Split, School of Medicine, University of Split, Split, Croatia.
Bajic Z; Scientific unit Dr. Mirko Grmek, Psychiatric Hospital Sveti Ivan, Zagreb, Croatia.
Dienes T; National Institute of Oncology, Budapest, Hungary.
Geczi L; National Institute of Oncology, Budapest, Hungary.

Neoplasma ; 68(1): 208-215, 2021 Jan.

Article en En | MEDLINE | ID: mdl-32940046

Asunto(s)

Antineoplásicos Inmunológicos; Carcinoma de Células Renales; Neoplasias Renales; Nivolumab; Anciano; Antineoplásicos Inmunológicos/efectos adversos; Carcinoma de Células Renales/tratamiento farmacológico; Carcinoma de Células Renales/patología; Croacia; Femenino; Humanos; Hungría; Neoplasias Renales/tratamiento farmacológico; Neoplasias Renales/patología; Masculino; Malta; Persona de Mediana Edad; Metástasis de la Neoplasia; Nivolumab/efectos adversos; Nivolumab/uso terapéutico; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Renales Tipo de estudio: Etiology_studies / Observational_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Neoplasma Año: 2021 Tipo del documento: Article País de afiliación: Croacia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google